• Headquarters: 1-781-935-3966



Healthcare Technologies (ADS)

Healthcare Technologies (ADS)

Analytic Diabetic Systems (ADS)

ADS is a predictive analytics company with expertise in AI and machine learning applied to several core healthcare system needs. Founded by Aptima, Inc.’s commercialization arm, Aptima Ventures LLC, ADS is the creator of GlyCU which provides predictive glycemic control analytics and monitoring to save lives, reduce labor, and decrease costs in the ICU.

Hospital Length of Stay chart
Comparison of survival curves based on hospital length of stay in surgical patients. Kaplan-Meir survivability plot shows a significant difference in mortality over hospital length of stay, between patients with controlled vs. uncontrolled blood glucose (P = 0.01). Figure courtesy of Andrew T. Schlussel, Danielle B. Holt, Eric A. Crawley, Michael B. Lustik, Charles E. Wade, Catherine F.T. Uyehara, Effects of Hyperglycemia and Continuous Intravenous Insulin on Outcomes of Surgical Patients, Journal of Surgical Research, Vol. 176, Issue 1, July 2012, pp. 202-209.

GlyCU Product Information

About Analytic Diabetic Systems (ADS)

ADS Team

ADS Board of Directors

For more information, please contact Jeffrey Morrill at jmorrill@analyticdiabeticsystems.com.